HK2 and sarcoma: In models of hepatitis B virus–related hepatocellular carcinoma (40) and in sarcoma cell lines (48), classical NFKB signaling (RELA) controls metabolic substrate preference in favor of glycolysis through transcriptional upregulation of HK2.